Clinical trial
Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous…
NCT00211445 · Manhattan Eye, Ear & Throat Hospital, Other · Completed
Key facts
| NCT number | NCT00211445 |
|---|---|
| Title | Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) |
| Lead sponsor | Manhattan Eye, Ear & Throat Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Central Serous Chorioretinopathy |
| Intervention type | Drug, Procedure |
| Interventions | Photodynamic Therapy with Verteporfin, verteporfin |
| Enrollment | 11 |
| Start date | Jul 1, 2002 |
| Completion | Jan 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 28, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: